Kistler Tiffany Companies LLC boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.2% during the first quarter, according to its most recent 13F filing with the SEC. The fund owned 3,566 shares of the healthcare conglomerate’s stock after buying an additional 176 shares during the period. Kistler Tiffany Companies LLC’s holdings in UnitedHealth Group were worth $585,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Ellington Management Group LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter worth about $528,000. Highland Capital Management LP bought a new stake in shares of UnitedHealth Group during the fourth quarter worth about $4,001,000. Retirement Systems of Alabama boosted its stake in shares of UnitedHealth Group by 2.5% in the first quarter. Retirement Systems of Alabama now owns 640,240 shares of the healthcare conglomerate’s stock worth $105,006,000 after buying an additional 15,403 shares during the period. Fiera Capital Corp boosted its stake in shares of UnitedHealth Group by 10.1% in the fourth quarter. Fiera Capital Corp now owns 630,755 shares of the healthcare conglomerate’s stock worth $100,945,000 after buying an additional 58,073 shares during the period. Finally, Polaris Capital Management LLC boosted its stake in shares of UnitedHealth Group by 23.5% in the fourth quarter. Polaris Capital Management LLC now owns 209,780 shares of the healthcare conglomerate’s stock worth $33,573,000 after buying an additional 39,884 shares during the period. 86.26% of the stock is currently owned by hedge funds and other institutional investors.
Shares of UnitedHealth Group Incorporated (UNH) traded up 0.06% during trading on Friday, reaching $194.88. The company’s stock had a trading volume of 2,892,259 shares. UnitedHealth Group Incorporated has a 12-month low of $132.39 and a 12-month high of $196.04. The company has a market cap of $191.96 billion, a PE ratio of 23.41 and a beta of 0.64. The company has a 50 day moving average of $186.80 and a 200 day moving average of $173.05.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The business had revenue of $50.05 billion for the quarter, compared to the consensus estimate of $49.97 billion. During the same period in the previous year, the business earned $1.96 earnings per share. The business’s revenue was up 7.7% on a year-over-year basis. On average, analysts anticipate that UnitedHealth Group Incorporated will post $9.87 EPS for the current fiscal year.
A number of analysts recently issued reports on UNH shares. Morgan Stanley increased their price objective on UnitedHealth Group from $202.00 to $210.00 and gave the stock an “overweight” rating in a report on Wednesday, June 28th. Deutsche Bank AG reissued a “buy” rating and set a $187.00 price objective (up previously from $183.00) on shares of UnitedHealth Group in a report on Saturday, April 22nd. Sanford C. Bernstein reissued an “outperform” rating and set a $190.00 price objective on shares of UnitedHealth Group in a report on Monday, July 10th. Oppenheimer Holdings, Inc. reissued an “outperform” rating and set a $205.00 price objective (up previously from $203.00) on shares of UnitedHealth Group in a report on Friday, July 21st. Finally, Zacks Investment Research cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Friday, May 19th. One analyst has rated the stock with a hold rating and twenty-four have given a buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $200.24.
In related news, Director Gail R. Wilensky sold 5,540 shares of the business’s stock in a transaction dated Friday, June 2nd. The stock was sold at an average price of $178.74, for a total value of $990,219.60. Following the sale, the director now directly owns 60,516 shares in the company, valued at $10,816,629.84. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction dated Wednesday, June 7th. The stock was sold at an average price of $182.64, for a total value of $913,200.00. Following the completion of the sale, the director now owns 75,735 shares in the company, valued at $13,832,240.40. The disclosure for this sale can be found here. Insiders sold 15,540 shares of company stock worth $2,873,320 over the last 90 days. Company insiders own 0.89% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with our FREE daily email newsletter.